(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 8.94% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Cvrx's revenue in 2025 is $52,870,000.On average, 3 Wall Street analysts forecast CVRX's revenue for 2025 to be $1,474,144,747, with the lowest CVRX revenue forecast at $1,471,016,036, and the highest CVRX revenue forecast at $1,478,316,363. On average, 3 Wall Street analysts forecast CVRX's revenue for 2026 to be $1,654,827,859, with the lowest CVRX revenue forecast at $1,521,596,878, and the highest CVRX revenue forecast at $1,739,042,353.
In 2027, CVRX is forecast to generate $1,774,109,999 in revenue, with the lowest revenue forecast at $1,571,916,994 and the highest revenue forecast at $1,976,303,004.